Global Sodium Hyaluronate-based Products Market Rise at 7.6% CAGR, to Reach USD 16.79 Billion By 2030

According to the research report, the global sodium hyaluronate-based products market was valued at USD 8.69 billion in 2021 and is expected to reach USD 16.79 Billion By 2030, growing at a CAGR of 7.6% during the forecast period.

The key factors responsible for the industry growth include the rising prevalence of osteoarthritis and cataracts. For instance, according to the Centers for Disease Control and Prevention, the most frequent type of arthritis is osteoarthritis (OA). These alterations normally take time to manifest and worsen. Pain, stiffness, and edema are all symptoms of OA. Over 32.5 million adults in the United States suffer from OA.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/sodium-hyaluronate-based-products-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Further, as per the Government of India (GOI), osteoarthritis is one of the most common rheumatologic conditions, which normally affects joints, with a prevalence rate of around 22 to 39%, in India. Women are more likely than males to develop OA. Approximately 45 percent of women over 65 have symptoms, while 70% of those over 65 have radiographic evidence of OA. According to the World Health Organization (WHO), symptomatic osteoarthritis affects 9.6% of men and 18.0% of women over 60 worldwide. 80 percent of people with osteoarthritis have movement limitations, and 25% are unable to conduct their major daily activities.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/12431

Based on the type, the injectable segment accounted for the largest revenue share in the industry in 2021. Due to a significant wide range of applications, such as dermal fillers in aesthetic procedures, pain treatment in osteoarthritis, surgical assistance in cataract extractions, and anti-adhesives in gynecological surgeries, the injectable type segment is growing.

Top Market Players Are:

Industry players such as Anika Therpeutics Inc., Galderma SA, Cadila Pharmaceuticals Ltd., Fidia Farmaceutici S.p.A., Allergan, Inc., BohusBioTech AB, Ferring Pharmaceuticals B.V., Syner-Med (Pharmaceutical Products) Ltd., and LG Chem Ltd are some key players operating in the global industry.

In July 2021, Coast Southwest announced the launch of EndiMoist. EndiMoist Hyaluronate-based is a high-purity sodium hyaluronate. EndiMoist offers a variety of Hyaluronate content in a variety of molecular weights to fulfill a variety of performances and usage needs. Enzymatic degradation produces EndiMoist MHA, a new generation of Oligo Hyaluronate. This novel technique has higher levels of safety and biological activity.

Browse detail report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/sodium-hyaluronate-based-products-market

Polaris Market research has segmented the sodium hyaluronate-based products market report based on type, application, and region:

Sodium Hyaluronate-based Products, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Topical
Injectable
Others

Sodium Hyaluronate-based Products, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Pharmaceuticals

Opthalmology
Orthopedic
Urology
Others

Cosmetics

Contact Us:
Polaris Market Research
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Ph: +1-929 297-9727

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

This release was published on openPR.